Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

Further Characterization of Proteolytic Clostridium botulinum Type A5 Reveals that Neurotoxin Formation Is Unaffected by Loss of the cntR (botR) Promoter Sigma Factor Binding Site

Andrew T. Carter, David R. Mason, Kathie A. Grant, Giovanna Franciosa, Paulo Aureli, Michael W. Peck
Andrew T. Carter
Institute of Food Research Foodborne Bacterial Pathogens Programme Norwich NR4 7UA, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andrew.carter@bbsrc.ac.uk
David R. Mason
Institute of Food Research Foodborne Bacterial Pathogens Programme Norwich NR4 7UA, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathie A. Grant
HPA Centre for Infections Foodborne Pathogens Reference Unit London NW9 5EQ, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanna Franciosa
Department of Food Safety and Veterinary Public Health Istituto Superiore di Sanità Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulo Aureli
Department of Food Safety and Veterinary Public Health Istituto Superiore di Sanità Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael W. Peck
Institute of Food Research Foodborne Bacterial Pathogens Programme Norwich NR4 7UA, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01774-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Although widely recognized as forming a deadly food-borne intoxicant, proteolytic Clostridium botulinum also infects humans, causing infant botulism after growth and neurotoxin formation in the gut (1) and wound botulism after contamination of a wound, often following injected drug abuse (8). The genes encoding the neurotoxin and its accessory proteins form two operons whose expression is induced by CntR (BotR), an alternative sigma factor (5). Comparative genomics of proteolytic C. botulinum recently identified four wound botulism strains as being closely related, each carrying identical copies of a new subtype (A5) of the A neurotoxin gene (3). These strains were isolated in 2004 from patients in four different United Kingdom cities. The close relationship between three of these strains has been confirmed by amplified fragment length polymorphism (AFLP) using the method of Brett et al. (2). In the present study, 22 isolates from wound botulism and two from food-borne botulism clustered into seven different AFLP types. Eleven isolates were AFLP type 1, including three of the four wound botulism strains (one was not tested). One of these strains, H04402 065, is further described here.

Pulsed-field gel electrophoresis (PFGE) and Southern analysis of strain H04402 065, performed according to the method of Franciosa et al. (6), showed that the neurotoxin gene cluster was chromosomally located, as with type A1 neurotoxin genes (10, 12), while some type A2 and all types A3 and A4 are plasmid borne (6, 12). DNA sequencing of this region revealed a truncated, nonfunctional type B3 gene (7) in the 3′ flank. Most interestingly, there was a 76-bp deletion in the intergenic region of cntC (ha33) and cntR (botR) (Fig. 1). Recently, a very similar arrangement in a type A5 infant botulism strain (IBCA94-0216) was reported by Dover et al. (4). The two type A5 neurotoxin clusters share 99.7% nucleotide sequence identity between the 3′ end of the cntE (ha70) gene and the 3′ end of the type B3 neurotoxin-encoding gene. Of the 41 nucleotide differences, 8 reside in the cntE (ha70) gene, and 29 are in the nonfunctional B3 neurotoxin-encoding gene. Importantly, we recognized that the 76-bp deletion specifically removed the −35 and −10 motifs situated upstream of cntR that had been identified as a putative CntR autoregulatory binding site (9). Of 38 other strains of proteolytic C. botulinum also possessing the ha + form of the neurotoxin gene cluster (8), selected as representing a wide range of diseases caused, geographical distribution and type of neurotoxin(s) formed (3), only the type B toxin-forming strain 2345 shared the same deletion, implying that this modification is quite rare. Dover et al. (4) suggested that the A5 neurotoxin gene, together with its cntB (ntnh) gene, may have been inserted into a type B neurotoxin cluster. Since microarray analysis showed that strain 2345 clustered with Clostridium sporogenes (3), it is tempting to postulate that a strain of C. sporogenes acquired a type B neurotoxin cluster by horizontal transfer to give a strain similar to strain 2345, which, following a further round of recombination at this locus, gave rise to the type A5 neurotoxin cluster now described.

Since type A5 strains lack what appears to be a key region of their cntR promoter, it was expected that the timing or extent of neurotoxin formation would be affected. To address this, neurotoxin formation was measured by enzyme-linked immunosorbent assay (ELISA) in duplicate batch cultures of the type A5 strain H04402 065 and the type A1 strain ATCC 3502. Surprisingly, no significant difference in neurotoxin formation was observed (Fig. 2), suggesting that the region is not essential for this function. How cntR expression is initiated and maintained in the absence of these binding motifs is not clear. The simplest option is for use of an adjacent but presently unidentified binding site. This implies that the alternative promoter region brought about by the deletion potentially coincides with the cntC gene promoter on the opposite DNA strand. This could cause transcriptional interference, a phenomenon in which overlapping promoters can cause one transcriptional unit to have a negative impact on its neighbor (11), one outcome of which might be reduced expression of the hemagglutinin-encoding operon. These hypotheses will be investigated by analysis of the transcriptome. The present observations suggest that the new type A5 strains may fortuitously offer the chance to dissect the control mechanisms of neurotoxin formation by proteolytic C. botulinum.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Position of a 76-bp deletion identified in the neurotoxin gene cluster of proteolytic C. botulinum type A5 strain H04402 065. Neurotoxins and associated genes are shaded. Prime symbols denote a partial gene. Upper part of figure represents coding regions spanning 18.2 kb of a chromosomal DNA sequence (GenBank accession number GQ477161). The −35 and −10 binding sites for the CntR/RNA polymerase complex are indicated for each gene that is positively regulated by CntR. Alternative nomenclature for neurotoxin cluster genes is as follows: cntC (ha34), cntD (ha17), cntE (ha70), cntR (botR), cntB (ntnh), cntA/A5 (bont/A5), cntA/B3′ (bont/B3′).

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Growth and neurotoxin formation by proteolytic C. botulinum type A5 strain H04402 065 (squares) and type A1 strain ATCC 3502 (triangles). Closed symbols represent the viable count (left y axis); open symbols represent the neurotoxin concentration in culture supernatant (right y axis).

  • Copyright © 2010 American Society for Microbiology

REFERENCES

  1. 1.↵
    Arnon, S. S. 2004. Infant botulism, p. 1758-1766. In R. D. Feigen, J. D. Cherry, G. J. Demmler, and S. L. Kaplan (ed.), Textbook of pediatric infectious disease. Saunders, Philadelphia, PA.
  2. 2.↵
    Brett, M. M., J. McLauchlin, A. Harris, S. O'Brien, N. Black, R. J. Forsyth, D. Roberts, and F. J. Bolton. 2005. A case of infant botulism with a possible link to infant formula milk powder: evidence for the presence of more than one strain of Clostridium botulinum in clinical specimens and food. J. Med. Microbiol. 54 : 769-776.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Carter, A. T., C. J. Paul, D. R. Mason, S. M. Twine, M. J. Alston, S. M. Logan, J. W. Austin, and M. W. Peck. 2009. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 10 : 115.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Dover, N., J. R. Barash, and S. S. Arnon. 2009. Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J. Clin. Microbiol. 47 : 2349-2350.
    OpenUrlFREE Full Text
  5. 5.↵
    Dupuy, B., and S. Matamouros. 2006. Regulation of toxin and bacteriocin synthesis in Clostridium species by a new subgroup of RNA polymerase sigma-factors. Res. Microbiol. 157 : 201-205.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Franciosa, G., A. Maugliani, C. Scalfaro, and P. Aureli. 2009. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PLoS One 4 : e4829.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Hill, K. K., T. J. Smith, C. H. Helma, L. O. Ticknor, B. T. Foley, R. T. Svensson, J. L. Brown, E. A. Johnson, L. A. Smith, R. T. Okinaka, P. J. Jackson, and J. D. Marks. 2007. Genetic diversity among botulinum neurotoxin-producing clostridial strains. J. Bacteriol. 189 : 818-832.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Peck, M. W. 2009. Biology and genomic analysis of Clostridium botulinum. Adv. Microb. Physiol. 55 : 183-320.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Raffestin, S., B. Dupuy, J. C. Marvaud, and M. R. Popoff. 2005. BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani. Mol. Microbiol. 55 : 235-249.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Sebaihia, M., M. W. Peck, N. P. Minton, N. R. Thomson, M. T. G. Holden, W. J. Mitchell, A. T. Carter, S. D. Bentley, D. R. Mason, L. Crossman, C. J. Paul, A. Ivens, M. H. J. Wells-Bennik, I. J. Davis, A. M. Cerdeno-Tarraga, C. Churcher, M. A. Quail, T. Chillingworth, T. Feltwell, A. Fraser, I. Goodhead, Z. Hance, K. Jagels, N. Larke, M. Maddison, S. Moule, K. Mungall, H. Norbertczak, E. Rabbinowitsch, M. Sanders, M. Simmonds, B. White, S. Whithead, and J. Parkhill. 2007. Genome sequence of a proteolytic (group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res. 17 : 1082-1092.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Shearwin, K. E., B. P. Callen, and J. B. Egan. 2005. Transcriptional interference-a crash course. Trends Genet. 21 : 339-345.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Smith, T. J., K. K. Hill, B. T. Foley, J. C. Detter, A. C. Munk, D. C. Bruce, N. A. Doggett, L. A. Smith, J. D. Marks, G. Xie, and T. S. Brettin. 2007. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids. PLoS One 2 : e1271.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Further Characterization of Proteolytic Clostridium botulinum Type A5 Reveals that Neurotoxin Formation Is Unaffected by Loss of the cntR (botR) Promoter Sigma Factor Binding Site
Andrew T. Carter, David R. Mason, Kathie A. Grant, Giovanna Franciosa, Paulo Aureli, Michael W. Peck
Journal of Clinical Microbiology Feb 2010, 48 (3) 1012-1013; DOI: 10.1128/JCM.01774-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Further Characterization of Proteolytic Clostridium botulinum Type A5 Reveals that Neurotoxin Formation Is Unaffected by Loss of the cntR (botR) Promoter Sigma Factor Binding Site
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Further Characterization of Proteolytic Clostridium botulinum Type A5 Reveals that Neurotoxin Formation Is Unaffected by Loss of the cntR (botR) Promoter Sigma Factor Binding Site
Andrew T. Carter, David R. Mason, Kathie A. Grant, Giovanna Franciosa, Paulo Aureli, Michael W. Peck
Journal of Clinical Microbiology Feb 2010, 48 (3) 1012-1013; DOI: 10.1128/JCM.01774-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacterial Proteins
Clostridium botulinum
Neurotoxins
Promoter Regions, Genetic
Sequence Deletion
Sigma Factor
Trans-Activators

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X